Holly A. Porter, Ph.D. - Publications
Affiliations: | 2012 | Molecular Medicine | University of Maryland School of Medicine, Baltimore, MD, United States |
Area:
Molecular Biology, Cell Biology, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2013 | Porter HA, Perry A, Kingsley C, Tran NL, Keegan AD. IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumors. Cancer Letters. 338: 239-48. PMID 23562473 DOI: 10.1016/J.Canlet.2013.03.030 | 0.595 | |||
2012 | Porter HA, Carey GB, Keegan AD. Insulin receptor substrate 1 expression enhances the sensitivity of 32D cells to chemotherapy-induced cell death. Experimental Cell Research. 318: 1745-58. PMID 22652453 DOI: 10.1016/J.Yexcr.2012.04.020 | 0.614 | |||
2010 | Porter HA, Keegan AD. Abstract 4014: Differential expression and activation of IRS1 and IRS2 in breast cancer cell lines Cancer Research. 70: 4014-4014. DOI: 10.1158/1538-7445.Am10-4014 | 0.603 | |||
2008 | Porter HA, Keegan AD. 16 IRS1 expression enhances the sensitivity of 32D cells to chemotherapy-induced cell death Cytokine. 43: 240. DOI: 10.1016/J.Cyto.2008.07.056 | 0.579 | |||
Show low-probability matches. |